➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Dr Reddys Labs Inc Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for DR REDDYS LABS INC, and what generic and branded alternatives to DR REDDYS LABS INC drugs are available?

DR REDDYS LABS INC has twenty-two approved drugs.

There are five tentative approvals on DR REDDYS LABS INC drugs.

Summary for Dr Reddys Labs Inc

US Patents:	0
Tradenames:	20
Ingredients:	20
NDAs:	22

Drugs and US Patents for Dr Reddys Labs Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys Labs Inc	AMVAZ	amlodipine maleate	TABLET;ORAL	021435-001	Oct 31, 2003		DISCN	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	076714-001	Oct 23, 2006	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	077130-004	Oct 31, 2007	AB	RX	No	Yes		Start Trial				Start Trial
Dr Reddys Labs Inc	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077183-003	Apr 15, 2010	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	NEFAZODONE HYDROCHLORIDE	nefazodone hydrochloride	TABLET;ORAL	076309-005	Sep 16, 2003		DISCN	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	IBUPROFEN	ibuprofen	TABLET;ORAL	076117-001	Nov 20, 2001		OTC	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	FLUCONAZOLE	fluconazole	TABLET;ORAL	076658-004	Jul 29, 2004	AB	RX	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Baxter

Merck

Mallinckrodt

Dow

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.